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Aims: Use of the polymerase chain reaction for the detection of Mycobacterium tuberculosis (TB PCR) as a
basis for making clinical decisions on the initiation of antituberculosis treatment was studied.
Methods: A retrospective study involving a cohort of 155 patients being investigated for tuberculosis in an
infectious disease consultation service was undertaken. TB PCR was performed on pulmonary and
extrapulmonary specimens from these patients. The sensitivity of TB PCR was analysed.
Results: Of the 155 patients, 144 fitted the clinical diagnosis of tuberculosis, and 112 of them were culture
positive for M tuberculosis. Sixty (58.3%) patients with clinical features suggestive of tuberculosis received
antituberculosis treatment based on positive TB PCR alone. Of 224 clinical specimens (138 pulmonary and
86 extrapulmonary) sent for TB PCR, 148 (99 pulmonary and 49 extrapulmonary) were positive in 117
patients. Of the 690 clinical specimens sent for culture, 279 were positive for M tuberculosis in 112
patients. The diagnostic sensitivity of TB PCR was 75.9% (85 of 112) and 81.3% (117 of 144) in patients
with culture confirmed and clinically diagnosed tuberculosis, respectively. Using culture as the gold
standard, the overall sensitivity of TB PCR was 78.3%, and for pulmonary and extrapulmonary specimens
it was 82.3% and 72.0%, respectively.
Conclusions: TB PCR is a rapid and reliable test in the diagnosis and management of tuberculosis.
I
n clinical practice, antituberculosis treatment is often
started purely on the basis of compatible clinical symptoms
and signs, suggestive radiological changes, and a rapid
microbiological test result, either a positive smear for acid
fast bacilli (AFB), and/or positive polymerase chain reaction
for tuberculosis (TB PCR). Confirmation of tuberculosis by
positive culture often takes three to six weeks. Even before
the availability of culture results, patients may have clinical
deterioration, which could be related to an alternative non-
tuberculosis infection, side effects of antituberculosis treat-
ment, antituberculosis drug resistance, or a paradoxical
response. The results of TB PCR testing can help to speed
up the decision making process involved in the diagnosis of
tuberculosis, so that early antituberculosis treatment can be
initiated. The laboratory performance of both commercial and
in house TB PCR in the diagnosis of tuberculosis has been
extensively evaluated.1–9 However, there are few data on the
‘‘in use’’ evaluation of TB PCR as a tool for clinical decision
making in the management of tuberculosis.
‘‘Confirmation of tuberculosis by positive culture often
takes three to six weeks’’
In our study, we report the management of a cohort of 155
patients with clinically suspected tuberculosis. We examined
the role of TB PCR using a manual, in house, single tube,
nested PCR of the IS6110 gene for the detection of
Mycobacterium tuberculosis as a rapid laboratory diagnostic test
in the initiation of antituberculosis treatment.
METHODS
Patients
Our study was performed at Queen Mary Hospital, a tertiary
hospital with a 1350 bed teaching hospital in Hong Kong,
from 1 July 2000 to 30 June 2002. During the study period, all
patients referred for infectious disease consultation with
clinical features suggestive of tuberculosis were recruited into
our study.
Microbiological investigation for M tuberculosis
We performed investigations for M tuberculosis, including AFB
smear examination and culture, on relevant clinical speci-
mens of all patients with suspected tuberculosis. TB PCR was
performed once a week on pulmonary and extrapulmonary
specimens in the following clinical settings: (1) patients with
typical radiological changes compatible with pulmonary
tuberculosis; (2) patients with radiological changes of old
tuberculosis but presenting with new pulmonary infiltrates;
(3) patients with community acquired pneumonia not
responding to appropriate antibiotic treatment; and (4)
patients undergoing invasive procedures, such as image
guided or surgical drainage and biopsy for sterile sites in
the investigation of extrapulmonary tuberculosis. Histological
examination for M tuberculosis was also performed if clinically
indicated.
Microbiological processing of clinical specimens
All specimens were collected in c irradiated disposable plastic
containers. A direct smear was prepared for the auramine
fluorescent stain and, if positive, the Ziehl-Neelsen stain was
performed for confirmation. The respiratory specimens were
decontaminated and digested by treatment with an equal
volume of sputolysin/sodium hydroxide (4%) for 30 minutes
at room temperature with rocking. After neutralisation with
20 ml of 0.067M sodium phosphate buffer (pH 5.3), the
mixture was centrifuged at 2750 6g for 30 minutes. After
discarding the supernatant, 400–500 ml of the sediment was
obtained. For early morning urine, 20 ml samples were
centrifuged at 2750 6g for 30 minutes. The sediments were
digested with 2% sodium hydroxide, followed by neutralisa-
tion with 0.067M phosphate buffer (pH 5.3). After cen-
trifugation, sediments were obtained. For the other
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: AFB, acid fast bacilli; PCR, polymerase chain reaction;
TB, Mycobacterium tuberculosis
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non-respiratory samples, such as sterile body fluid or tissue
aspirates, specimens were microcentrifuged at 12 000 6g for
10 minutes to collect the sediments. For sediments of both
respiratory and non-respiratory specimens, about 60 ml of the
sediment was inoculated into two Lowenstein-Jensen med-
ium culture bottles and incubated at 37 C˚ for up to eight
weeks. Solid medium slants were considered positive when
visible colonies grew. The colonies were further confirmed as
mycobacteria by the Ziehl-Neelsen stain. Cultures positive for
AFB were identified by the AccuProbe hybridisation assay
(Gen-Probe, San Diego, California, USA), according to the
manufacturer’s instructions. For mycobacteria other than
M tuberculosis, conventional biochemical tests were performed
for identification.
The rest of the sediment was transferred to an Eppendorf
tube and stored at 220 C˚ if not immediately processed.
Manual one tube nested PCR for the IS6110 gene
sequence for the detection of M tuberculosis
For the digested sediments, the Roche Cobas Amplicor
(Roche Diagnostics, Berlin, Germany) extraction protocol
was used, as described previously.8 9 A volume of 500 ml wash
solution was mixed with the sediment. After centrifugation
at 15 000 6g for 10 minutes the supernatant was decanted,
100 ml of lysis reagent was added, and the mixture was
vortexed, followed by incubation at 60 C˚ for 45 minutes.
Extraction was terminated by adding 100 ml of neutralisation
reagent. Each PCR reaction contained 10 ml of the DNA
extract. The two sets of primers used for amplification were
derived from the gene sequence encoding the insertion
sequence IS6110 as follows: external primers were derived
from position 367 to 392 (59-CCGGCCAGCACGCTAATTA
ACGGTTC-39) and position 769 to 746 (59-TGTGGCCGGAT
CAGCGATCGTGGT-39); and internal primers were derived
from position 455 to 472 (59-CTGCACACAGCTGACCGA-39)
and position 670 to 652 (59-CGTTCGACGGTGCATCTG-39).
The reaction mixture consisted of 10mM Tris/HCl (pH 8.3),
50mM KCl, 2mM MgCl2, 0.15mM dATP, dGTP, dCTP,
0.45mM dUTP, 2 pmol external primers, 75 pmol internal
primers, 2 U AmpliTaq Gold polymerase (Perkin Elmer,
Foster City, California, USA), and 0.5 U heat labile uracil-
N-glycosylase (Roche Diagnostics) in a total reaction volume
of 100 ml. The mixture was first incubated at 37 C˚ for 10
minutes with uracil-N-glycosylase to destroy any contam-
inating amplicons, and then at 94 C˚ for 12 minutes to
activate the AmpliTaq polymerase, followed by subsequent
temperature cycling at 94 C˚ for 45 seconds and 72 C˚ for 1.5
minutes for the first 15 cycles, followed by 94 C˚ for 45
seconds, 55 C˚ for 45 seconds, and 72 C˚ for one minute for 45
cycles. Positive and negative controls were included in each
run and all precautions to prevent cross contamination were
observed. Amplified products were electrophoresed through a
2% agarose gel in Tris borate buffer. Target bands of 21 bp
were visualised by staining with ethidium bromide.
Diagnosis and treatment of M tuberculosis
Preliminary diagnosis of M tuberculosis was based on a positive
AFB smear, TB PCR, or tissue histology results during the
initial investigation. A definitive diagnosis of tuberculosis
was made by positive culture results. For those patients with
negative culture for M tuberculosis, a clinical diagnosis was
made by an investigators’ consensus with respect to the
clinical and radiological presentation and progression,
tuberculin skin tests, haematological findings, histological
findings (when available), and clinical response to antitu-
berculosis treatment.
Antituberculosis treatment was given to patients with a
preliminary or definitive diagnosis of tuberculosis, or
empirically if clinical suspicion of M tuberculosis was high.
RESULTS
Patients
During the two year study period, there were 5315 inpatient
infectious disease consultations from various clinical special-
ties. One hundred and fifty five patients with clinical
symptoms and signs suggestive of tuberculosis were recruited
into our study and managed according to fig 1. Definitive
diagnosis of tuberculosis was documented in 112 patients by
positive culture for M tuberculosis. Another 32 patients were
diagnosed as having tuberculosis based on clinical consensus
among the investigators. Of these 144 patients, 94 had
pulmonary tuberculosis, 31 had extrapulmonary tuberculosis,
and 19 had combined pulmonary and extrapulmonary
tuberculosis. The remaining 11 patients were determined
not to have tuberculosis and alternative diagnoses were
made.
Microbiological investigation for M tuberculosis
In total, 437 pulmonary specimens (sputum, bronchial
aspirates, bronchoalveolar lavage, and gastric aspirates) and
253 extrapulmonary (cerebrospinal fluid, pleural effusion,
peritoneal fluid, joint fluid, bone marrow aspiration, bone
biopsy, tissue biopsy, lymph nodes, urine, and stools)
specimens were obtained for AFB smear and culture
examinations in 155 patients. Eighty eight smears were
positive in 35 patients and 279 cultures were positive for
M tuberculosis in 112 patients, respectively. The diagnostic
sensitivity of the AFB smear was 31.3% (35 of 112) and 24.3%
(35 of 144) in culture confirmed and clinically diagnosed
tuberculosis, respectively. The yield from AFB culture was
77.8% when clinical diagnosis was used as reference.
In total, 224 clinical specimens were requested from 155
patients for TB PCR (138 pulmonary specimens and 86
extrapulmonary specimens), in which 148 specimens (99
pulmonary specimens and 49 extrapulmonary specimens)
were positive in 117 patients. Figure 2 shows the correlations
between TB PCR and AFB smear and culture results. One
sample in one patient with a positive AFB smear who was
culture positive for M tuberculosis showed negative results in
the TB PCR test. A PCR inhibitor was detected in the sample
extract from this patient. Eight patients with histological
features of tuberculosis but who were negative in TB PCR had
positive M tuberculosis cultures. Thirty four patients with a
positive smear and TB PCR had a positive culture for
M tuberculosis. Another 83 patients had a negative smear
and a positive TB PCR in the initial investigation, but culture
was subsequently positive in 51 patients. Those patients with
a positive TB PCR but a negative culture had clinical and
radiological results that were suggestive of active tubercu-
losis. TB PCR was positive in 85 of 112 patients who were
culture positive for M tuberculosis. The diagnostic sensitivity of
TB PCR was 75.9% (85 of 112) and 81.3% (117 of 144) in
culture confirmed and clinically diagnosed tuberculosis,
respectively. TB PCR was positive in 101 of the 129 specimens
(79 pulmonary specimens and 50 extrapulmonary speci-
mens) where cultures were positive. The overall sensitivity of
the assay was 78.3%, and that of pulmonary and extra-
pulmonary specimens was 82.3% and 72.0%, respectively
(table 1). In the 11 patients in whom an alternative diagnosis
other than tuberculosis was made, 54 and 11 clinical
specimens were negative for mycobacterial culture and TB
PCR, respectively, resulting 100% specificity of TP PCR. Tissue
specimens were available in 20 patients for histological
examination and 12 of them had evidence of mycobacterial
infection.
Diagnosis and treatment of M tuberculosis
In the initial investigation, 121 patients had laboratory
evidence of M tuberculosis infection, which included AFB
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smear and TB PCR positive in 34, AFB smear positive but TB
PCR negative in one, AFB smear negative but TB PCR positive
in 78, and histological features of mycobacterial infection in
eight patients. Standard antituberculosis treatment including
isoniazid, rifampicin, pyrazinamide, and ethambutol was
given to 103 patients when the initial work up results became
available. Thirty four (33%) of 103 patients were treated
because of positive smear and TB PCR results, and 60 (58.3%)
patients received antituberculosis therapy based on positive
TB PCR results. Treatment was started because of a positive
AFB smear result in one and a positive histological result
alone in eight patients. Antituberculosis treatment was not
Figure 1 Decision for initiating antituberculosis treatment (anti-TB Rx) in 155 patients based on clinical and laboratory findings. TB PCR, polymerase
chain reaction for Mycobacterium tuberculosis.
Figure 2 The correlation between
polymerase chain reaction for
Mycobacterium tuberculosis (TB PCR)
and conventional work up for
M tuberculosis in 155 patients. *Those
patients with positive TB PCR but
negative culture results had clinical and
radiological results that were suggestive
of active tuberculosis.
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given in 18 patients because of severe comorbidity in 15, an
advanced age of 102 in one, and the patient’s refusal for fear
of potential side effects of treatment in two, despite positive
TB PCR results at the initial investigation for TB. In 34
patients with negative AFB smears, empirical antitubercu-
losis treatment was given as above while waiting for the TB
PCR results in 10 (6.9%) patients. There was pulmonary or
miliary tuberculosis in six patients, tuberculous meningitis in
three, and tuberculous spondylitis and peritonitis in one. Five
of these 10 patients turned out to have a positive TB PCR
within five days of starting treatment. The remaining 24
patients with negative results in both the AFB smear and TB
PCR were investigated further and an alternative diagnosis
was made in 11 patients. Fourteen patients received
antituberculosis treatment when the culture results were
available, including two patients who refused initial treat-
ment. Therefore, 127 (82%) of 155 patients received
antituberculosis treatment in this cohort, of whom 118
completed the course of treatment. Nine patients defaulted
follow up after the initiation of treatment.
DISCUSSION
The decision to initiate antituberculosis treatment based on
the pretreatment nucleic acid amplification assay on both
respiratory and non-respiratory specimens was studied. In
our series, of 144 patients with a clinical diagnosis of
M tuberculosis infection, only 25% had positive results on
AFB smear examination, but about 80% had a positive TB
PCR assay result. Almost 60% patients received antitubercu-
losis treatment based on positive TB PCR as the sole result in
the initial investigation, and more than 70% of them had
subsequent culture confirmation of M tuberculosis. Without
this rapid assay, delay in giving the appropriate treatment
would probably have occurred.
Although the Food and Drug Administration of the USA
recommended that PCR should only be performed for rapid
diagnosis in respiratory specimens of either AFB smear
positive or negative samples,10 nucleic acid amplification has
been studied extensively in patients with extrapulmonary
tuberculosis using either in house or commercial kits. The
sensitivity ranged between 42% and 93% in culture positive
specimens.6 11–15 Our centre uses a manual in house, single
tube, nested PCR using IS6110 as a target site for the rapid
diagnosis of pulmonary and extrapulmonary tuberculosis,5–7
with a specificity of 99.7%.6 7 The manual assay also showed
comparable results to the commercial kits when respiratory
specimens were evaluated.8 9 In our study, the overall
sensitivity of the TB PCR assay was 78.3%, and 72% for
extrapulmonary specimens, which is similar to that seen in
another centre using IS6110 as a target site for laboratory
diagnosis.4 However, the result for pleural fluid in our study
was particularly poor, with a sensitivity of only 33.3%, in
contrast to another study, which found the sensitivity of PCR
to be 81% for pleural fluid.16 The presence of inhibitors could
not explain the discrepancy in these results. Interestingly, we
found a positive TB PCR in an endocervical swab, which has
not been reported in the literature.
‘‘Of 144 patients with a clinical diagnosis of
Mycobacterium tuberculosis infection, only 25% had
positive results on acid fast bacilli smear examination,
but about 80% had a positive Mycobacterium tuberculosis
polymerase chain reaction result’’
Although TB PCR appears to be a rapid, sensitive, and
specific diagnostic assay, the results should be interpreted
with care in the clinical setting. In our study, 32 patients had
a positive TB PCR but a negative culture subsequently. In
such cases, there is a clinical dilemma of whether anti-
tuberculosis treatment should be maintained or discontin-
ued. As long as precautions have been taken to avoid cross
contamination, the positive TB PCR may indicate the
presence of non-viable AFB, particularly in patients with a
history of tuberculosis in the past. However, a negative AFB
culture cannot preclude a clinical diagnosis of tuberculosis,
particularly in patients with clinical and radiological features
suggestive of active tuberculosis, as demonstrated in our
patients. There can be a variety of reasons for a positive TB
PCR but negative AFB culture. For example, the M tuberculosis
count may be low at the tissue level or the organisms may not
be viable as a result of the decontamination procedure used
when handling respiratory specimens.17 Therefore, TB PCR
can be used to complement culture in selected patients.
Table 1 Evaluation of TB PCR in culture confirmed Mycobacterium tuberculosis
Total number of
culture positive
specimens
Number of TB
PCR positive
samples
Number of TB
PCR negative
samples
Sensitivity of TB
PCR
Pulmonary specimens 79 65 14 82.3%
Sputum 39 31 8 79.5%
Bronchoalveolar lavage 40 34 6 85%
Extrapulmonary specimens 50 36 14 72%
Tissue 16 13 3 81.2%
Aspirates 13 9 4 69.2%
Cerebrospinal fluid 10 8 2 80%
Pleural fluid 6 2 4 33.3%
Early morning urine 4 3 1 75%
Endocervical swab 1 1 0 100%
Total 129 101 28 78.3%
TB PCR, polymerase chain reaction for Mycobacterium tuberculosis.
Take home messages
N The polymerase chain reaction for Mycobacterium
tuberculosis (TB PCR) is a rapid and reliable method for
the diagnosis of both pulmonary and extrapulmonary
tuberculosis, with an overall sensitivity of 78.3% and a
specificity of 100%
N It enabled antituberculosis treatment to be started early
in more than half of the patients studied
N Because of the relatively low sensitivity of TB PCR,
clinical judgment remains the ultimate decision in the
management of tuberculosis
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Recent advances in the molecular diagnosis of tuberculosis
involving the detection of bacterial mRNA encoding the
ubiquitous 85B antigen in viable M tuberculosis by reverse
transcriptase PCR and reverse transcriptase strand displace-
ment amplification assay may overcome the above diffi-
culty.18–20 Because the mRNA is more rapidly destroyed in the
cells than rRNA or genomic DNA, having a half life of only a
few minutes, it can differentiate between viable and non-
viable M tuberculosis. Thus, it may become useful for the
diagnosis of active tuberculosis and provide a tool to monitor
the therapeutic efficacy.
In conclusion, TB PCR is a rapid and reliable method in the
diagnosis of tuberculosis, which allowed early initiation of
antituberculosis treatment in more than 50% of the studied
patients in our cohort. However, because of the relatively low
sensitivity of TB PCR, clinical judgment remains the ultimate
decision in the management of tuberculosis.
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